Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16

被引:47
作者
Cabrera-Rode, E
Sarmiento, L
Tiberti, C
Molina, G
Barrios, J
Hernández, D
Díaz-Horta, O
Di Mario, U
机构
[1] Natl Inst Endocrinol, Dept Innumol Diabet, Havana, Cuba
[2] Inst Trop Med Pedro Kouri, Havana, Cuba
[3] Univ Roma La Sapienza, Med Clin 2, Rome, Italy
关键词
islet cell antibodies; insulin autoantibodies; glutamic acid decarboxylase antibodies; tyrosine phosphatase antibodies; virus; enterovirus; echovirus; neutralizing antibodies; Type; 1; diabetes;
D O I
10.1007/s00125-003-1179-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. To determine whether the emergent infection by echovirus 16 that occurred in Cuba during the year 2000 was related to the presence of Type 1 diabetes associated autoantibodies. Methods. The presence of ICA, IAA, GADA, IA2 antibodies and neutralizing antibodies (NtAb) to echovirus 16 were determined in sera from 38 infected children and adolescents and 80 control subjects, matched in sex, age, local residence and time of sample collection. Results. The occurrence of a large-scale echovirus 16 epidemic was associated with the appearance of humoral autoimmune markers of Type 1 diabetes, especially for ICA, IAA and GADA. In the convalescent stage, ICA, IAA and GADA seroconversion was shown in 92.1%, 44.7% and 28.9% of echovirus 16 infected subjects. None of the 80 uninfected subjects had ICA or IAA, while one was GADA positive. ICA, IAA and GADA frequency was higher in the convalescent than in the acute stage (p<0.0005). A strong positive correlation was found between the NtAb to echovirus 16 and ICA titres in both acute and convalescent stage (r=0.91; p<0.0001, r=0.55; p=0.0003 respectively). Conclusion/interpretation. This work provides evidence of an association between echovirus 16 infection and the presence of Type 1 diabetes related antibodies (ICA, IAA and GADA). Our data show that the echovirus 16 infection might be capable of inducing a process of autoimmune beta-cell damage and support the hypothesis that enterovirus infections are important risk factors for the development of Type 1 diabetes.
引用
收藏
页码:1348 / 1353
页数:6
相关论文
共 50 条
  • [21] Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment
    Cabrera-Rode, E
    Perich, P
    Diaz-Horta, O
    Tiberti, C
    Molina, G
    Arranz, C
    Martin, JM
    Licea, M
    De Leiva, A
    Puig-Domingo, M
    Dimario, U
    AUTOIMMUNITY, 2002, 35 (07) : 469 - 474
  • [22] Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes
    Vantyghem, MC
    Fajardy, I
    Pigney, P
    Noel, C
    Kerr-Conte, J
    Gmyr, V
    Vandewalle, B
    Proye, C
    Pattou, F
    DIABETES & METABOLISM, 2003, 29 (06) : 595 - 601
  • [23] Insulin antibodies are prevalent in adults with type 1 diabetes referred for islet cell transplantation and are modified by islet transplantation and immunosuppression: an Australian experience
    Hensman, Callum J.
    Gooley, Judith L.
    Januszewski, Andrzej S.
    Lee, Melissa H.
    Maclsaac, Richard J.
    Boston, Raymond C.
    Ward, Glenn M.
    Jenkins, Alicia J.
    INTERNAL MEDICINE JOURNAL, 2022, 52 (08) : 1434 - 1436
  • [24] Sugar intake is associated with progression from islet autoimmunity to type 1 diabetes: the Diabetes Autoimmunity Study in the Young
    Lamb, Molly M.
    Frederiksen, Brittni
    Seifert, Jennifer A.
    Kroehl, Miranda
    Rewers, Marian
    Norris, Jill M.
    DIABETOLOGIA, 2015, 58 (09) : 2027 - 2034
  • [25] Engineered antibodies for type 1 diabetes
    Hampe, Christiane S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (04) : 336 - 345
  • [26] Biofabrication of a vascularized islet organ for type 1 diabetes
    Citro, Antonio
    Moser, Philipp T.
    Dugnani, Erica
    Rajab, Konrad T.
    Ren, Xi
    Evangelista-Leite, Daniele
    Charest, Jonathan M.
    Peloso, Andrea
    Podesser, Bruno K.
    Manenti, Fabio
    Pellegrini, Silvia
    Piemonti, Lorenzo
    Ott, Harald C.
    BIOMATERIALS, 2019, 199 : 40 - 51
  • [27] INSULITIS AND ISLET MICROVASCULATURE IN TYPE-1 DIABETES
    PAPACCIO, G
    HISTOLOGY AND HISTOPATHOLOGY, 1993, 8 (04) : 751 - 759
  • [28] Understanding Islet Autoantibodies in Prediction of Type 1 Diabetes
    Jia, Xiaofan
    Yu, Liping
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 8 (01)
  • [29] RISK FOR DEVELOPING TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS AND THE PRESENCE OF ISLET 64K ANTIBODIES
    BARMEIER, H
    MCCULLOCH, DK
    NEIFING, JL
    WARNOCK, G
    RAJOTTE, RV
    PALMER, JP
    LERNMARK, A
    DIABETOLOGIA, 1991, 34 (10) : 727 - 733
  • [30] Poor beta-cell function after the clinical manifestations of type 1 diabetes in children initially positive for islet cell specific autoantibodies
    Komulainen, J
    Knip, M
    Lounamaa, R
    Vahasalo, P
    Karjalainen, J
    Sabbah, E
    Akerblom, HK
    Tuomilehto, J
    Toivanen, L
    Virtala, E
    Pitkaniemi, J
    Fagerlund, A
    Flittner, M
    Gustafsson, B
    Haggquist, C
    Hakulinen, A
    Herva, L
    Hiltunen, P
    Huhtamaki, T
    Huttunen, NP
    Huupponen, T
    Hyttinen, M
    Joki, T
    Jokisalo, R
    Kaar, ML
    Kallio, S
    Kaprio, EA
    Kaski, U
    Laine, L
    Lappalainen, J
    Maenpaa, J
    Makela, AL
    Niemi, K
    Niiranen, A
    Nuuja, A
    Ojajarvi, P
    Otonkoski, T
    Pihlajamaki, K
    Pontynen, S
    Rajantie, J
    Sankala, J
    Schumacher, J
    Sillanpaa, M
    Stahlberg, MR
    Strahlmann, CH
    Uotila, T
    Vare, M
    Varimo, P
    Wetterwstrand, G
    Aro, A
    DIABETIC MEDICINE, 1997, 14 (07) : 532 - 537